MedPath

浙江迪耳药业有限公司

Ownership
-
Established
1996-04-05
Employees
-
Market Cap
-
Website
http://www.deyer.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

67

NMPA:67

Drug Approvals

Pamidronate Disodium

Product Name
帕米膦酸二钠
Approval Number
国药准字H20056170
Approval Date
Jul 31, 2024
NMPA

Amantadine Hydrochloride

Product Name
盐酸金刚烷胺
Approval Number
国药准字H33020317
Approval Date
Jun 18, 2024
NMPA

Diclofenac Sodium Sustained-release Tablets

Product Name
双氯芬酸钠缓释片
Approval Number
国药准字H20083921
Approval Date
Jun 5, 2023
NMPA

Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Sustained-release Tablets

Product Name
西替伪麻缓释片
Approval Number
国药准字H20080409
Approval Date
Mar 3, 2023
NMPA

Ofloxacin Suppositories

Product Name
氧氟沙星栓
Approval Number
国药准字H20073919
Approval Date
Aug 19, 2022
NMPA

续断总皂苷提取物

Approval Number
国药准字Z20070053
Approval Date
Aug 5, 2022
NMPA

续断壮骨胶囊

Approval Number
国药准字Z20070054
Approval Date
Jul 26, 2022
NMPA

Tinidazole Suppositories

Product Name
替硝唑栓
Approval Number
国药准字H20066491
Approval Date
May 10, 2021
NMPA

产后逐瘀片

Approval Number
国药准字Z20063888
Approval Date
Apr 23, 2021
NMPA

Amorolfine　Hydrochloride　Liniment

Product Name
盐酸阿莫罗芬搽剂
Approval Number
国药准字H20065886
Approval Date
Apr 23, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.